Exploring a new treatment for cervical precancer in HIV-positive women in South Africa
Acceptability and feasibility of combination treatment for cervical precancer among South Africa women living with HIV
This study is looking at a new way to help women with HIV in South Africa who have precancerous cervical lesions by combining a minor surgery with a simple, low-cost cream to lower their chances of developing cervical cancer.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of North Carolina Chapel Hill NIH-funded |
| Lab location | 1 site (Chapel Hill, United States) |
| Project ID | NIH-10870205 on NIH RePORTER |
What this research studies
This research investigates a novel treatment approach for cervical precancerous lesions in women living with HIV in South Africa. It aims to assess the acceptability and feasibility of using a combination of surgical excision followed by self-applied topical 5-fluorouracil (5FU), a low-cost medication, to reduce the risk of cervical cancer. By focusing on a population that is often underserved in terms of cancer treatment, the study seeks to provide a patient-centered solution that can be easily implemented in low-resource settings.
Who could benefit from this research
Good fit: Ideal candidates for this research are women living with HIV who have been diagnosed with cervical intraepithelial neoplasia grade 2 or 3 (CIN2/3).
Not a fit: Patients who do not have cervical precancer or are not living with HIV may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly lower the rates of cervical cancer among HIV-positive women by providing an effective treatment option for precancerous conditions.
How similar studies have performed: Previous studies in the U.S. have shown efficacy for similar treatment approaches, indicating potential for success in this novel application.
Where this research is happening
Chapel Hill, United States
- Univ of North Carolina Chapel Hill — Chapel Hill, United States (Active)
Researchers
- Principal investigator: Chibwesha, Carla J — Univ of North Carolina Chapel Hill
- Study coordinator: Chibwesha, Carla J
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.